Suchergebnisse - "Paolo Gaibani"

PubPharm (37)

1

Whole Genome Sequencing of a

in: Current Issues in Molecular Biology | 2023

von Antonella Marangoni | Stefano Amadesi | Marielle Ezekielle Djusse | +4

2

Comparison of Broth Microdilution, Disk Diffusion and Strip Test Methods for Cefiderocol Antimicrobial Susceptibility Testing on KPC-Producing

in: Antibiotics | 2023

von Federica Bovo | Tiziana Lazzarotto | Simone Ambretti | +1

3

Synergistic Activity of Cefiderocol in Combination with Piperacillin-Tazobactam, Fosfomycin, Ampicillin-Sulbactam, Imipenem-Relebactam and Ceftazidime-Avibactam against Carbapenem-Resistant Gram-Negative Bacteria

in: Antibiotics | 2023

von Marta Palombo | Federica Bovo | Stefano Amadesi | +1

4

In Vitro Evaluation of Increasing Avibactam Concentrations on Ceftazidime Activity against Ceftazidime/Avibactam-Susceptible and Resistant KPC-Producing

in: Antibiotics | 2023

von Marta Palombo | Benedetta Secci | Federica Bovo | +3

5

Dengue and falciparum malaria co-infection in travelers returning from Burkina Faso: Report of two cases in Northeastern Italy

in: Asian Pacific Journal of Tropical Medicine | 2023

von Antonio Mastroianni | Caterina Vocale | Vittorio Sambri | +4

6

Resistance to Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam in Gram-Negative MDR Bacilli: Molecular Mechanisms and Susceptibility Testing

in: Antibiotics | 2022

von Paolo Gaibani | Tommaso Giani | Federica Bovo | +6

7

Successful Treatment of Bloodstream Infection due to a KPC-Producing Klebsiella Pneumoniae Resistant to Imipenem/Relebactam in a Hematological Patient

in: Microorganisms | 2022

von Paolo Gaibani | Linda Bussini | Stefano Amadesi | +5

8

Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in patients colonized with Candida spp.

in: International Journal of Infectious Diseases | 2022

von Elisa Viciani | Paolo Gaibani | Andrea Castagnetti | +7

9

Successful Treatment of Bacteremia and Ventilator-Associated Pneumonia Caused by KPC/OXA-48-like

in: Infectious Disease Reports | 2022

von Pier Giorgio Cojutti | Giacomo Fornaro | Milo Gatti | +5

10

Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant

in: Antibiotics | 2022

von Milo Gatti | Maddalena Giannella | Matteo Rinaldi | +3